Interactions between glioma and pregnancy: insight from a 52-case multicenter series by S. Peeters et al.
Interactions between glioma and pregnancy: insight from a
52-case multicenter series
Submitted by Beatrice Guillaumat on Wed, 12/05/2018 - 15:31
Titre Interactions between glioma and pregnancy: insight from a 52-case multicenter series
Type de
publication Article de revue
Auteur
Peeters, Sophie [1], Pagès, Mélanie [2], Gauchotte, Guillaume [3], Miquel, Catherine
[4], Cartalat-Carel, Stéphanie [5], Guillamo, Jean-Sébastien [6], Capelle, Laurent [7],
Delattre, Jean-Yves [8], Beauchesne, Patrick [9], Debouverie, Marc [10], Fontaine,
Denys [11], Jouanneau, Emmanuel [12], Stecken, Jean [13], Menei, Philippe [14], De
Witte, Olivier [15], Colin, Philippe [16], Frappaz, Didier [17], Lesimple, Thierry [18],
Bauchet, Luc [19], Lopes, Manuel [20], Bozec, Laurence [21], Moyal, Elisabeth [22],
Deroulers, Christophe [23], Varlet, Pascale [24], Zanello, Marc [25], Chretien, Fabrice
[26], Oppenheim, Catherine [27], Duffau, Hugues [28], Taillandier, Luc [29], Pallud,
Johan [30]
Editeur American Association of Neurological Surgeons












OBJECTIVE The goal of this study was to provide insight into the influence of gliomas
on gestational outcomes, the impact of pregnancy on gliomas, and the identification of
patients at risk. METHODS In this multiinstitutional retrospective study, the authors
identified 52 pregnancies in 50 women diagnosed with a glioma. RESULTS For
gliomas known prior to pregnancy (n = 24), we found the following: 1) An increase in
the quantified imaging growth rates occurred during pregnancy in 87% of cases. 2)
Clinical deterioration occurred in 38% of cases, with seizures alone resolving after
delivery in 57.2% of cases. 3) Oncological treatments were immediately performed
after delivery in 25% of cases. For gliomas diagnosed during pregnancy (n = 28), we
demonstrated the following: 1) The tumor was discovered during the second and third
trimesters in 29% and 54% of cases, respectively, with seizures being the presenting
symptom in 68% of cases. 2) The quantified imaging growth rates did not significantly
decrease after delivery and before oncological treatment. 3) Clinical deterioration
resolved after delivery in 21.4% of cases. 4) Oncological treatments were immediately
performed after delivery in 70% of cases. Gliomas with a high grade of malignancy,
negative immunoexpression of alpha-internexin, or positive immunoexpression for p53
were more likely to be associated with tumor progression during pregnancy.
Deliveries were all uneventful (cesarean section in 54.5% of cases and vaginal
delivery in 45.5%), and the infants were developmentally normal. CONCLUSIONS
When a woman harboring a glioma envisions a pregnancy, or when a glioma is
discovered in a pregnant patient, the authors suggest informing her and her partner
that pregnancy may impact the evolution of the glioma clinically and radiologically.
They strongly advise a multidisciplinary approach to management. ■
CLASSIFICATION OF EVIDENCE Type of question: association; study design: case
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